Clinical Trial

Multiple Sclerosis, Sarcopenia and Respiration

Completed
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to evaluate the relationship between respiratory function and sarcopenia in people with multiple sclerosis. The main questions it aims to answer are: Is there a relationship between muscle structure and respiratory muscle strength/pulmonary function in MS patients? Undergo a single session of respiratory muscle strength measurement (e.g., maximal inspiratory pressure \[MIP\], maximal expiratory pressure \[MEP\]) Perform spirometry to assess pulmonary function
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-02.
Status change: Not Yet Recruiting → Completed 2026-03-26
Trial Details
NCT Number NCT07152015
Lead Sponsor Uskudar University
Conditions Multiple Sclerosis
Enrollment 40 participants
Start Date 2025-09-05
Primary Completion 2025-09-15 (estimated)
Study Completion 2025-09-20 (estimated)
Updated on ClinicalTrials.gov 2026-04-01